Rare Pharma Private Limited, a active private limited company, was established on 28 December 1989 in Badlapur, Maharashtra, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U99999MH1989PTC054794. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.95 M.
It upholds a compliant status. Its leadership includes Pramila Rajendra Pawar (Director), Rajendra Maruti Pawar (Director). Past directors included Bina Omprakash Dhoot, Chandrasen Valmik Shinde, Omprakash Shobhachand Dhoot. It holds ₹6.89 M open charges and ₹1.15 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at W-82(B), Badlapur Midc, Badlapur, Maharashtra, 421503.
U99999MH1989PTC054794
054794
28 December 1989
₹1.00 M
₹0.95 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Rare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pramila Rajendra Pawar | Director | 21 Oct 2019 | Current |
| Rajendra Maruti Pawar | Director | 21 Oct 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 01 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rare Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1694.85% increase. The company also saw a substantial fall in profitability, with a 60.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 141.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rare Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹6,891,665.00
₹11,450,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2022 | Yes Bank Limited | ₹6.89 M | Open |
| 13 Oct 2007 | Janakalyan Sahakari Bank Limited | ₹0.70 M | Satisfied |
| 13 Oct 2007 | Janakalyan Sahakari Bank Limited | ₹2.70 M | Satisfied |
| 13 Oct 2007 | Janakalyan Sahakari Bank Limited | ₹0.20 M | Satisfied |
| 18 Mar 2002 | Janakalyan Sahakari Bank Ltd | ₹4.20 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rare Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Rare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Yes Bank Limited amounted to Rs. 6.89 M with Charge ID 100726296 was registered on 08 Dec 2022. was completed.
Pramila Rajendra Pawar was appointed as a Director was appointed as a Director on 21 Oct 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.
Progress on Rajendra Maruti Pawar was appointed as a Director was appointed as a Director on 21 Oct 2019 & has been associated with this company since 6 years 1 month . was documented.
Progress on A charge registered on 30 Jan 1991 via Charge ID 90363375 with State Bank Of India was fully satisfied on 27 Feb 2017. was documented.
The CIN of Rare Pharma Private Limited is U99999MH1989PTC054794.
Rare Pharma Private Limited is headquartered at W-82(B), Badlapur Midc, Badlapur, Maharashtra, 421503.
Rare Pharma Private Limited was incorporated on 28 December 1989.
The current directors of Rare Pharma Private Limited are
The primary industry of Rare Pharma Private Limited is Manufacturing.
Rare Pharma Private Limited is unlisted.
The authorized capital of Rare Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.95 M.
The compliance status of Rare Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX